BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Hanmi Pharmaceutical Advances Global GLP 1 Strategy With Mexico Distribution Agreement For Efpeglenatide

Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obesity and metabolic disease ...

January 29, 2026 | News

SK Bioscience Advances Zaire Ebolavirus Vaccine Development With CEPI Backed Global Collaboration

SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition for Epidemi...

January 23, 2026 | News

Samsung Biologics Strengthens Long Term Growth Platform With Solid 2025 Financial Performance

Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent ...

January 22, 2026 | Company results

Alteogen Signs Exclusive Global Licensing Deal With GSK Subsidiary Tesaro For ALT B4

Alteogen Inc. (KOSDAQ: 196170) announced that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK...

January 21, 2026 | News

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...

January 19, 2026 | News

Formosa Pharmaceuticals Secures Strategic Korea Commercial Partner For Its FDA Approved Ophthalmic Therapy

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Sam...

January 13, 2026 | News

Samsung Bioepis Takes Full Control Of BYOOVIZ Commercialisation In Europe

Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ® BYOOVIZ becomes the fourth biosimila...

January 05, 2026 | News

TempraMed Technologies Ltd Expands South Korea Presence With New Commercial Order And Extended Distribution Partnership

TempraMed Technologies Ltd, a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is excited to announc...

January 05, 2026 | News

KLMBio Accelerates Global Expansion With High Value Human Tissue Based Bone Graft Portfolio

KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value ti...

January 01, 2026 | News

ABL Bio Lands Strategic 55 Million Funding Boost To Fast Track Next Wave Of Breakthrough Antibody Therapies

Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on co...

December 29, 2025 | News

SN Bioscience Secures US FDA Orphan Drug Designation For SNB 101 In Gastric Cancer

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (incl...

December 25, 2025 | News

GC Biopharma Secures MFDS Approval For Phase 1 Trial Of mRNA Covid 19 Vaccine Candidate

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform GC Biopharma (...

December 24, 2025 | News

Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site

- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...

December 22, 2025 | News

MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy

MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...

December 19, 2025 | News

Stay Connected